Additional Information
| Size: | 100 µl | 
| Target: | Aurora B | 
| Conjugate: | ATTO 633 | 
| Research Area: | Cancer | Cell Cycle | Cell Division | Spindle | Cell Signaling | Protein Phosphorylation | Serine / Threonine Kinases | Aurora |Cell Signaling | Protein Phosphorylation | Epigenetics and Nuclear Signaling | Chromatin Modifying Enzymes | 
| Alternative Name: | AIK2 Antibody, ARK2 Antibody, Aurora related Kinase 2 Antibody, IPL1 Antibody, STK1 Antibody, Aurora 1 Antibody | 
| Category: | Antibodies | 
| Product Type: | Polyclonal Antibody | 
| Immunogen: | Synthetic peptide of human Aurora B (AA2-16) | 
| Immunogen Species: | Human | 
| Applications: | WB, AM | 
| Host: | Rabbit | 
| Isotype: | N/A | 
| Species Reactivity: | Human, Mouse | 
| Antibody Dilution: | WB (1:250); optimal dilutions for assays should be determined by the user. | 
| Purification: | Peptide Affinity Purified | 
| Storage Buffer: | PBS pH7.4, 50% glycerol, 0.025% Thimerosal | 
| Concentration: | N/A | 
| Specificity: | Detects 39.28 kDa. | 
| Storage: | -20ºC | 
| Shipping: | Blue Ice or 4ºC | 
| Certificate of Analysis: | A 1:250 dilution of SPC-1107 was sufficient for detection of Aurora B in 10 µg of HeLa cell lysate by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody. | 
| Cellular Localization: | Nucleus, Cytoplasm, Cytoskeleton | 
| Tissue Specificity: | High level expression seen in the thymus. It is also expressed in the spleen, lung, testis, colon, placenta and fetal liver. Expressed during S and G2/M phase and expression is up-regulated in cancer cells during M phase | 
| Accession Number: | NP_004208 | 
| Gene ID: | 9212 | 
| Swiss-Prot: | Q96GD4 | 
| Field of Use: | For in vitro research use only. | 
 
             
             
             
             
             
             
             
             
             
            